Seasonal allergic rhinitis (hayfever) Respiratory Vasomotor and allergic rhinitis
Conditions
Interventions
The randomisation is at the level of the general practice, i.e. the practices are the clusters.
The health care professional intervention is a one day short course entitled 'Essential Asthma and All
Sponsors
Chief Scientist Office of the Scottish Executive Health Department (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Young people (both males and females) aged 12 - 18 years 2. Hayfever, defined by the presence of a documented clinician diagnosis in the patient's health record and any evidence of treatment used for allergic rhinitis
Exclusion criteria
Exclusion criteria: 1. Unable to give consent 2. Taking part in any other clinical trials involving treatment for allergic rhinitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in the validated Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score between the intervention and control groups at baseline and 3 and 6 weeks post-intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Symptom scores, assessed using a visual analogue scale at 3 and 6 weeks post intervention 2. Overall assessment of seasonal allergic rhinitis symptoms compared with the previous season, assessed 6 weeks post intervention 3. Number of general practitioner and practice nurse consultations for hayfever; prescribed (from clinical records) and over-the-counter (from patients) medication data will be collected for cost-effectiveness comparison. Theses will be assessed at end of hayfever period (September 2009) 4. Examination performance, assessed at end of hayfever period (September 2009) 5. Assessment of change in clinical practice on completion of trial | — |
Countries
United Kingdom
Outcome results
None listed